Inflammatory bowel disease stories

Oct 19, 2026

Gilead's oral drug succeeds in mid-stage inflammatory bowel disease trial

Gilead Sciences reported that its oral treatment eliminated symptoms in patients with inflammatory bowel disease in a mid-stage clinical trial.

Oct 19, 20262 sources

May 5, 2026

Johnson & Johnson's IBD Therapy Fails to Meet Primary Endpoint in Clinical Trial

Johnson & Johnson's closely watched inflammatory bowel disease therapy failed to show statistically significant improvement in patients during clinical trials, representing a setback for the pharmaceutical giant's gastroenterology pipeline.

May 5, 20261 source